Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
The assessment of non-feminizing estrogens for use in neuroprotection
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The assessment of non-feminizing estrogens for use in neuroprotection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Neuroprotection
100%
Non-feminizing Estrogens
100%
Estrogen
75%
Neuroprotective Action
50%
Estrogen Receptor-α (ER-α)
50%
Neuroprotective
25%
Neuronal Cell Death
25%
Adverse Effects
25%
Postmenopausal Women
25%
17-estradiol
25%
A-ring
25%
In Vitro Effect
25%
Orally Administered
25%
Menopause
25%
Steroid Hormones
25%
Feminizing Effect
25%
Women's Health Initiative
25%
Bulky Groups
25%
Feminizing
25%
Binding Capacity
25%
Neuroscience
Neuroprotection
100%
Estrogen
100%
Neuroprotective Agent
42%
In Vitro
28%
Estrogen Receptor Alpha
28%
In Vivo
14%
Neuronal Cell Death
14%
Diethylstilbestrol
14%
Steroids
14%
Steroid Hormone
14%
Side Effect
14%
Pharmacology, Toxicology and Pharmaceutical Science
Neuroprotection
100%
Estrogen
100%
Neuroprotective Agent
42%
Estrogen Receptor Alpha
28%
Diethylstilbestrol
14%
Steroids
14%
Steroid Hormone
14%
Side Effect
14%
Veterinary Science and Veterinary Medicine
Estrogen
100%
Estrogen Receptor Alpha
28%
In Vitro
28%
Steroid Hormone
14%
Diethylstilbestrol
14%